Titan Pharmaceuticals Inc (TTNP)
3.92
-0.11
(-2.73%)
USD |
NASDAQ |
Nov 05, 11:41
Titan Pharmaceuticals Total Assets (Quarterly): 4.35M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 4.35M |
| March 31, 2024 | 6.646M |
| December 31, 2023 | 8.086M |
| September 30, 2023 | 9.999M |
| June 30, 2023 | 0.812M |
| March 31, 2023 | 2.168M |
| December 31, 2022 | 4.058M |
| September 30, 2022 | 6.276M |
| June 30, 2022 | 8.319M |
| March 31, 2022 | 10.32M |
| December 31, 2021 | 7.994M |
| September 30, 2021 | 9.637M |
| June 30, 2021 | 11.51M |
| March 31, 2021 | 13.82M |
| December 31, 2020 | 8.087M |
| September 30, 2020 | 8.018M |
| June 30, 2020 | 9.762M |
| March 31, 2020 | 13.26M |
| December 31, 2019 | 9.522M |
| September 30, 2019 | 5.304M |
| June 30, 2019 | 6.761M |
| March 31, 2019 | 11.44M |
| December 31, 2018 | 14.10M |
| September 30, 2018 | 11.85M |
| June 30, 2018 | 4.617M |
| Date | Value |
|---|---|
| March 31, 2018 | 5.29M |
| December 31, 2017 | 8.905M |
| September 30, 2017 | 12.74M |
| June 30, 2017 | 9.414M |
| March 31, 2017 | 13.07M |
| December 31, 2016 | 18.67M |
| September 30, 2016 | 23.54M |
| June 30, 2016 | 25.30M |
| March 31, 2016 | 12.00M |
| December 31, 2015 | 13.29M |
| September 30, 2015 | 14.91M |
| June 30, 2015 | 17.31M |
| March 31, 2015 | 18.39M |
| December 31, 2014 | 20.85M |
| September 30, 2014 | 13.22M |
| June 30, 2014 | 14.25M |
| March 31, 2014 | 16.12M |
| December 31, 2013 | 18.42M |
| September 30, 2013 | 15.52M |
| June 30, 2013 | 16.91M |
| March 31, 2013 | 23.53M |
| December 31, 2012 | 24.83M |
| September 30, 2012 | 10.74M |
| June 30, 2012 | 10.05M |
| March 31, 2012 | 7.509M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.812M
Minimum
Jun 2023
13.82M
Maximum
Mar 2021
8.034M
Average
8.087M
Median
Dec 2020
Total Assets (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 15.72M |
| Perspective Therapeutics Inc | 385.92M |
| Protalix BioTherapeutics Inc | 91.54M |
| Electromed Inc | 52.23M |
| Armata Pharmaceuticals Inc | 108.31M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.356M |
| Shareholders Equity (Quarterly) | 3.994M |